Using single cell sequencing to explore the difference in tumor- associated macrophages between left and right colon cancer and evaluate the prognosis of patient

Author:

Liao Kaili1,Hu Yujie2,Zhao Hanqing3,Sun Bing3,Fu Yuxin4,Zhang Jingyan3,Sun Xiaomeng3,Xiong Zhenfang5,Wang Xiaozhong1

Affiliation:

1. the Second Affiliated Hospital of Nanchang University

2. The First Clinical Medical College of Nanchang University

3. Queen Mary college of Nanchang University

4. School of Public Health of Nanchang University

5. the First Affiliated Hospital of Nanchang University

Abstract

Abstract

This research investigates the role of TAMs in left and right colon cancer progression, utilizing scRNA-seq to identify variances in TAMs and their microenvironment. We gathered macrophages from 12 left and 6 right colon cancer tissue samples, identifying 325 marker genes. Patients were stratified into three subgroups based on the expression of marker gene, which facilitated the examination of tumor microenvironment differences, immune cell infiltration, and immune checkpoint expression differences. WGCNA further identified 27 TAM characteristic genes. Two genes, CXCR4 and RGS2, were selected as prognostic genes through multivariate Cox regression analysis. Using these genes, we have created a TAM-related prognosis evaluation model, which was validated using external datasets. Our findings suggest that TAM-related genes have prognostic significance in colon cancer, offering potential therapeutic targets for left and right colon cancer treatment.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3